Yuhan

Yuhan makes $325M cancer bet to challenge Boehringer, Takeda
Fierce Pharma
Wed, 05/31/23 - 06:59 pm
Yuhan
cancer
Boehringer Ingelheim
Takeda
HER2 inhbitor
non-small cell lung cancer
Boehringer races to catch up in NASH through Yuhan deal
BioCentury
Mon, 07/1/19 - 10:47 pm
Boehringer Ingelheim
NASH
Yuhan
Sorrento and Yuhan Secure $40 Million for Immuno-Oncology Joint Venture
CP Wire
Tue, 02/12/19 - 10:02 am
Sorrento Therapeutics
Yuhan
ImmuneOncia
immuno-oncology
Sorrento and Yuhan Secure $40 Million for Immuno-Oncology Joint Venture
Tue, 02/12/19 - 09:55 am
Sorrento Therapeutics
Yuhan
ImmuneOncia
immuno-oncology
Gilead Inks $785 Million Deal With Yuhan for NASH Development
BioSpace
Mon, 01/7/19 - 11:16 am
Gilead Sciences
NASH
South Korea
Yuhan
In another try at lung cancer niche, J&J nabs a potential Tagrisso rival for $50M-plus
Endpoints
Mon, 11/5/18 - 07:17 pm
JNJ
Tagrisso
AstraZeneca
Yuhan